Improving the Supply of Critical Medications for Pediatric and Adult Cancer Patients
Columbus, OH – August 1, 2024 – STAQ Pharma, a hospital-owned 503B outsourcing supplier committed to alleviating drug shortages, announced the launch of their oncology portfolio at a ceremony held at their Columbus, OH, facility on Friday, July 26. The oncology portfolio begins with methotrexate, an essential treatment widely used for pediatric cancer patients. STAQ Pharma hopes to provide relief for hospital and healthcare system supply chains as an onshore supplier with the release of its first commercial batch of oncology medications.
The successful production of methotrexate comes from their newest manufacturing facility in Columbus, OH, which was specifically designed to produce hazardous drugs such as oncology medications. In addition to the production of essential oncology drugs, the Columbus facility addresses drug shortages in the sterile injectable market. Read more >
STAQ Pharma is a leading automated Outsourcing Facility with operating locations in Denver, CO and Columbus, OH. At STAQ Pharma, our trusted reputation demonstrates our commitment to the safety, transparency, availability, and quality of the products we manufacture. With our established and growing product catalog, we ship to over 400 locations nationwide on a daily basis.
This post is related to:
Admixture Compounding Services (503B Outsourcing Facilities) Health System Pharmacy Resources
